Forehead/brow/soft-tissue surgery for migraines

Soft-Tissue Surgery of the Craniofacial Region

Volumn , Issue , 2007, Pages 93-111

  Guyuron, Bahman ^a   DiNardo, Lisa A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951672166     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (78)

1. Lipton RB, Steward WF, Diamond S, et al. Prevalence and burden of migraine in the united states: data from the american migraine study II. Headache 2001; 41(7): 646-657.
2. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994; 44(6 suppl 4): S17-S23.
3. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the united states: Disability and economic costs. Arch Intern Med 1999; 159(8): 813-818.
4. Stewart WF, Lipton RB, Kolodner KB, et al. Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 2000; 88(1): 41-52.
5. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the united states: relation to age, income, race and other sociodemographic factors. JAMA 1992; 267: 64-69.
6. Welch KMA. Drug therapy of migraine. N Engl J Med 1993; 329: 1476-1483.
7. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002; 346(4): 257-270.
8. Guyuron B, Varghai A, Michelow BJ, et al. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg 2000; 106: 429-434.
9. Guyuron B, Tucker T, Davis J. Surgical treatment of migraine headaches. Plast Reconstr Surg 2003; 112(suppl 5s): 164S-170S.
10. Guyuron B, Kriegler JS, Davis J. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg 2005; 115(1): 1-9.
11. MedicineNet.com. Migraine headache. Available at: www.medicinenet.com/script/main/art.asp? articlekey=417&pf=3&track=qpa417 (accessed October 27, 2004).
12. Headache classification committee of the international headache society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(suppl 7): 1-96.
13. Russell MB, Olesen J. The genetics of migraine without aura and with aura. Cephalalgia 1993; 13(4): 245-248.
14. Gardner K. The genetic basis of migraine: How much do we know? Can J Neurol Sci 1999; (suppl 3): S37-S43.
15. Joutel A, Bousser MG, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993; 5(1): 40-45.
16. Silberstein SD, Lipton RB. 21st century prevention and management of migraine headaches. Clinical Courier 2001; 19(8): 1-16.
17. Dandy WE. Treatment of hemicrania (migraine) by removal of the inferior cervical and first thoracic sympathetic ganglion. Johns Hopkins University Bulletin 1931; 48: 357-361.
18. Gardner WJ, Stowell A, Dutlinger R. Resection of the greater superficial petrosal nerve in the treatment of unilateral headache. J Neurol 1947; 4: 105-114.
19. Murillo CA. Resection of the temporal neurovascular bundle for control of migraine headache. Headache 1968; 8(3): 112-117.
20. Murphy JP. Occipital neurectomy in the treatment of headache. Md State Med J 1969; 18(6): 62-66.
21. Maxwell RE. Surgical control of chronic migrainous neuralgia by trigeminal ganglio-rhizolysis. J Neurosurg 1982; 57(4): 459-466.
22. Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003; 16(1): 39-42.
23. Silberstein SD. Neurotoxins in the neurobiology of pain. Headache 2003; 43(suppl 1): S1-S8.
24. Dodick DW. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside. Headache 2003; 43(suppl 1): S25-S33.
25. Blersch W, Schulte-Mattler WJ, Przywara S, et al. Botulinum Toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study. J Neurol Sci 2002; 205: 59-63.
26. Binder WJ, Brin MF, Blitzer A, et al. Botulinum toxin A (BTX-A) for the treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 2000; 123: 669-676.
27. Mathew N, Kaup A. The use of Botulinum toxin type A in headache treatment. Curr Treatmnt Opt in Neur 2002; 4: 365-373.
28. Brin MF, Swope DM, O’Brien C, et al. Botox for migraine: double-blind, placebo-controlled, regionspecific evaluation. Cephalalgia 2000; 20: 421-422.
29. Blumenfeld AM, dodick DW, Silberstein SD. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Dermatol Clin 2004; 22(2): 167-175.
30. Welge-Luessen A, Hauser R, Schmid N, et al. Endonasal surgery for contact point headaches: a 10-year longitudinal study. Laryngoscope 2003; 113 (12): 2151-2156.
31. Clerico DM, Evan K, Montgomery L, et al. Endoscopic sinonasal surgery in the management of primary headaches. Rhinology 1997; 35: 98-102.
32. Novak VJ, Makek M. Pathogenesis and surgical treatment of migraine and neurovascular headaches with rhinogenic trigger. Head & Neck 1992; 14: 467-472.
33. Kunachak S. Middle turbinate lateralization: A simple treatment for rhinologic headache. Laryngoscope 2002; 112: 870-872.
34. Mosser SW, Guyuron B, Janis JE. The anatomy of the greater occipital nerve: implications for the etiology of migraine headaches. Plast Reconstr Surg 2004; 113(2): 693-697.
35. Dirnberger F, Becker K. Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg 2004; 114(3): 652-657.
36. Welch KMA. Contemporary concepts of migraine pathogenesis. Neurology 2003; 61(suppl 4): S2-S8.
37. Welch KMA, D’Andrea G, Tepley N, et al. The concept of migraine as a state of central neuronal hyperexcitability. Headache 1990; 8: 817-828.
38. Hadjikhani N, Sanchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001; 98: 4687-4692.
39. Waeber C, Moskowitz MA. Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology 2003; 61(suppl 4): S9-S20.
40. Goadsby PJ. Pathophysiology of headache. In: Silberstein SD, Lipton RB, Solomon S, eds. Wolff’s Headache and Other Head Pain, 7th edn. Oxford, England: Oxford University Press, 2001: 57-72.
41. Feindel W, Penfield W, NcNaughton F. The tentorial nerves and localization of intracranial pain in man. Neurology 1960; 10: 555-563.
42. Goadsby PJ, Hoskin KL. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat 1997; 190: 367-375.
43. Hoskin KL, Zagami AS, Goadsby PJ. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat. J Anat 1999; 194: 579-588.
44. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cerebr Blood Flow Metab 1999; 19: 115-127.
45. Dimitriadou V, Buzzi MG, Theoharides TC, et al. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 1992; 48: 187-203.
46. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994; 117(Pt 1): 199-210.
47. Goadsby PJ, Hoskin KL. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat 1997; 190(Pt 3): 367-375.
48. Strassman AM, Mineta Y, Vos BP. Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. J Neurosci 1994; 14: 3725-3735.
49. Kaube H, Keay K, Hoskin KL, et al. Expression of c-Fos-like Immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 1993; 629: 95-102.
50. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 2002; 125(7): 1496-1509.
51. Uddman R, Edvinsson L, Ekman R, et al. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 1985; 62: 131-136.
52. Chen LYL, Gillespie SA, Norregaard TV, et al. Co-localization of retrogradely transported wheat germ agglutinin and the putative neurotransmitter substance P within trigeminal ganglion cells projecting to cat middle cerebral artery. J Comp Neurol 1984; 225: 187-192.
53. Edvinsson L, Brodin E, Jansen I, et al. Neurokinin A in cerebral vessels: characterization, localization and effects in vitro. Regul Peptides 1988; 20: 181-197.
54. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28: 183-187.
55. Ebersberger A, Averbeck B, Messlinger K, et al. Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 1999; 89: 901-907.
56. Dash KS, Janis JE, Rohrich RJ, et al. Lesser and third occipital nerve study. Plast Reconstr Surg 2005; 115: 1752-1758.
57. Totonchi A, Pashmini N, Guyuron B. The zygomaticotemporal branch of the trigeminal nerve: an anatomical study. Plast Reconstr Surg 2005; 115(1): 273-277.
58. Neumann S, Doubell TP, Leslie T, et al. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996; 384(6607): 360-364.
59. Woolf CJ. Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci 1996; 351(1338): 441-448.
60. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996; 384: 560-564.
61. Burstein R, Yamamura H, Malick A, et al. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998; 79: 964-982.
62. Yamamura H, Malick A, Chamberlin NL, et al. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 1999; 81(2): 479-493.
63. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol 2000b; 47: 614-624.
64. Burstein R, Cutrer FM, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000a; 123: 1703-1709.
65. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001; 89: 107-110.
66. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 2004; 55: 27-36.
67. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55: 19-26.
68. Levy D, Jakubowski M, Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5-HT (1B/D) receptor agonists. Proc Natl Acad Sci USA 2004; 101: 4274-4279.
69. Bennett GJ, Zie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107.
70. Hu JW, Sessle BJ, Raboisson P, et al. Stimulation of craniofacial muscle afferents induces prolonged facilitatory effects in trigeminal nociceptive brain-stem neurones. Pain 1992; 48(1): 53-60.
71. Yu XM, Sessle BJ, Hu JW. Differential effects of cutaneous and deep application of inflammatory irritant on mechanoreceptive field properties of trigeminal brain stem nociceptive neurons. J Neurophysiol 1993; 70(4): 1704-1707.
72. Wall PD, Woolf CJ. Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol 1984; 356: 443-458.
73. Goadsby PJ, Knight YE, Hoskin KL. Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain 1997; 73(1): 23-28.
74. Angus-Leppan H, Lambert GA, Michalicek J. Convergence of occipital nerve and superior sagittal sinus input in the cervical spinal cord of the cat. Cephalalgia 1997; 17(6): 635-630.
75. Chow JM. Rhinologic headaches. Otolaryngol Head Neck Surg 1994; 111: 211-216.
76. Wanamaker HH. Role of Haller’s cell in headache and sinus disease: a case report. Otolaryngol Head Neck Surg 1996; 114: 324-327.
77. Guyuron B, Michelow BJ, Thomas T. Corrugator supercilii muscle resection through blepharoplasty incision. Plast Reconstr Surg 1995; 95(4): 691-696.
78. Guyuron B, Rose K. Harvesting fat from the infratemporal fossa. Plast Reconstr Surg 2004; 114: 245-249.